The United States has lost a measles elimination designation it had held for 26 years, amid its largest outbreak in more than three decades. The country had achieved elimination in 2000, but health authorities have now found sustained circulation of the virus.

On Tuesday, the Pan American Health Organization (PAHO), the World Health Organization’s Americas branch, declared measles endemic in the US, Bolivia and Mexico. It found that, in each country, the same viral strain had circulated without interruption for at least 12 months. PAHO Director Dr Jarbas Barbosa accepted an international advisory panel’s recommendation to withdraw elimination status.

PAHO reviewed epidemiological and laboratory evidence supplied by the US Centers for Disease Control and Prevention (CDC). The countries losing their designation must provide corrective action plans in the coming weeks, while PAHO expects to send them recommendations within the next few days.

Cases and vaccination coverage

CDC figures show approximately 7,700 US infections since the start of 2025. The agency has confirmed six measles-related deaths in 2026, whereas officials in Pennsylvania, Wisconsin and New York have reported 10 combined. The difference has contributed to federal-state tensions over classification and counting.

Measles is highly infectious, and the WHO estimates it killed 95,000 people globally in 2024, most of them children. US preschool vaccination coverage has dropped to about 92 percent, below what experts consider necessary to prevent major outbreaks.

Vaccine hesitancy has grown under Health Secretary Robert F Kennedy Jr, who has repeatedly questioned vaccine safety despite contrary scientific evidence. Kennedy has also questioned protection from the combined measles, mumps and rubella vaccine, or MMR, and made a claim about its contents that experts rejected as false.

In a joint statement Tuesday, the CDC said it remained committed to ending outbreaks and recovering elimination status. Director Erica Schwartz said vaccination protects Americans, rather than the designation. The agency reported approximately $100m in additional funding since August for state and local vaccination, surveillance and outbreak response.

Calls for a wider response

Matt Ferrari, a biology professor who directs Pennsylvania State University’s Center for Infectious Disease Dynamics, told Al Jazeera the loss should humble the US. He said its earlier achievement had encouraged elimination programmes worldwide, but the country now needed to seek expertise elsewhere.

University of Colorado professor Edwin Asturias said measles cases indicate problems with immunisation and other public health services. He estimated that adults older than 20 account for about 40 percent of current US cases and advocated reaching them through workplaces, places of worship and other community settings.

Ferrari suggested states consider changing dose timing for young children where measles is circulating. He cited Pennsylvania’s June recommendation for an additional early dose for infants aged six months and older in areas with sustained transmission as an example of local adaptation.

US children routinely receive two MMR doses, typically at 12 to 15 months and then at four to six years. Two doses are about 97 percent effective against measles. Where transmission is more widespread, countries often give the second dose between 18 and 24 months.

Some experts hope state and local departments will act, though they do not expect a major federal policy shift. Schwartz said last week that the CDC would maintain its existing response if elimination status were lost. Asturias questioned whether federal public health leadership could reverse the outbreak.